Mounjaro is not yet approved for weight loss in the US even though there is strong evidence that it will be, and there's little question that there has generally been weight loss in those taking it for diabetes.
Recent studies have very clearly shown it's effective for weight loss even in those without diabetes, but there's a lag as the FDA reviews those studies. Until then, Lilly simply can't advertise it as a treatment for obesity.
It’s not weird at all if you’re aware of the regulations.
Drug companies can’t promote a drug for something it’s not FDA approved for (off-label promotion). Companies face multi-billion dollar penalties for doing so.
Mounjaro is approved for type 2 diabetes. And weight loss is a great way to help get your type 2 diabetes under control.
So highlighting that it helps type 2 patients lose weight, while having an FDA mandated disclosure that it’s not approved for weight loss alone, makes perfect sense.
Small text underneath: "Mounjaro is not a weight loss drug."
Man, the US pharma industry/marketing is so weird.
https://www.mounjaro.com/#:~:text=mounjaro%20is%20not%20a%20....